Galenica AG
· ISIN: CH0360674466
· EQS - Company News
Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors
Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor
Smart tools for smart investors can be found in our Tools section
Corporate News Galenica AG
In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
This might be interesting for you as well
23 January 2025 07:00AM
Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors
Galenica AG
/ Key word(s): Personnel
Galenica nominates Nadine Balkanyi-Nordmann for the Board of Directors 23.01.2025 / 07:00 CET/CEST
Press release
Nadine Balkanyi-Nordmann, an experienced legal, compliance and governance expert, will be recommended for election as a member of the Board of Directors at the next Annual Genera...
Galenica AG
23 January 2025 06:45AM
Galenica reports strong sales growth once again
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales once again performed very positively in 2024, with growth of 4.7% to CHF 3,922 million. As a result, Galenica outperformed the entire pharmaceutical market in terms of growth (+3.5%, IQVIA, Pharmaceutical Market Switzerland, YTD December 2024).
Following a solid increase ...
Galenica AG
24 October 2024 06:45AM
Galenica increases sales growth in the third quarter
Press releaseAd hoc announcement pursuant to Art. 53 LR
Following solid sales growth of 2.6% in the first half of 2024, Galenica grew more strongly again in the third quarter and generated net sales of CHF 2,864.8 million to the end of September 2024. With growth of 4.1%, Galenica outperformed the growth of the overall pharmaceutical market (+2.9%,...
Galenica AG
06 August 2024 07:00AM
Expansion of the Executive Committee and handover of the position of CFO
Galenica AG
/ Key word(s): Strategic Company Decision
Expansion of the Executive Committee and handover of the position of CFO 06.08.2024 / 07:00 CET/CEST
Press release
Galenica is aligning its pharmacy business to an even greater focus on customers. With Stephan Mignot, Marketing for the pharmacies will have a direct seat on ...
Galenica AG
06 August 2024 06:45AM
Galenica achieves solid growth in a challenging market environment
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales grew by 2.6% to CHF 1,900.0 million in the first half of 2024. Both the “Products & Care” segment and the “Logistics & IT” segment contributed to the sales growth, with growth of 3.1% and 3.0% respectively. As a result, Galenica Group sales developed more dynamical...
Galenica AG
22 July 2024 06:11PM
Galenica increases shareholding in Redcare Pharmacy to 10%
Galenica AG
/ Key word(s): Investment
Galenica increases shareholding in Redcare Pharmacy to 10% 22.07.2024 / 18:11 CET/CEST
Press release
Today, Galenica notified the Dutch Authority for the Financial Markets (AFM) of its 10% stake in Redcare Pharmacy N.V.
As part of the strategic partnership between Galenica and Redcare Phar...
Galenica AG
23 May 2024 06:45AM
Galenica on track with sales growth
Press releaseAd hoc announcement pursuant to Art. 53 LR
The Galenica Group made a good start to the new year with sales growth of 4.8% to CHF 1,255.5 million in the first four months of 2024. All Service Units performed well and contributed to the good sales performance.
The sales growth is based on a positive development of the pharmaceutical ma...
Galenica AG
16 April 2024 06:05PM
Galenica successfully places a bond of over CHF 100 million
Galenica AG
/ Key word(s): Bond
Galenica successfully places a bond of over CHF 100 million 16.04.2024 / 18:05 CET/CEST
Press release
Today, Galenica successfully placed a fixed rate bond of over CHF 100 million.
The bond has a term of 7 years and an annual coupon of 1.65%. The proceeds from the transaction will be used for g...
Galenica AG
10 April 2024 05:29PM
Shareholders approve all proposals
Galenica AG
/ Key word(s): AGMEGM
7th Annual General Meeting: Shareholders approve all proposals 10.04.2024 / 17:29 CET/CEST
Press release
The seventh Annual General Meeting of Galenica Ltd. was held on 10 April 2024 at the Kursaal in Bern. The shareholders approved all the proposals put forward by the Board of Directors. They...
Galenica AG
12 March 2024 06:45AM
Galenica continues to grow in the 2023 financial year
Press releaseAd hoc announcement pursuant to Art. 53 LR
The Galenica Group achieved strong growth with an increase in sales of 4.4% in the 2023 financial year and generated consolidated net sales of CHF 3,746.0 million. Adjusted for the extraordinary sales related to COVID-19 (self-tests, COVID-19 vaccinations and rapid tests) in the prior-year per...
Galenica AG
18 January 2024 06:45AM
Galenica again achieves strong sales growth
Press releaseAd hoc announcement pursuant to Art. 53 LR
Galenica Group sales performed well in 2023, growing by 4.4% to CHF 3,746.0 million. As expected, sales growth of 3.3% in the second half of 2023 was lower than the +5.5% recorded in the first half due to the exceptionally strong comparative period in the second half of 2022, when there was a ...
Galenica AG
More Galenica AG related information
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Corporate Research | 0 | - | - | Corporate Research |
| Directors Dealings | 0 | - | - | DD |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.
v.07062023 EN